BDBM646015 (2S,4R)-4-hydroxy-1-((2R)-2-(3-(2-(2-(2- hydroxyphenyl)-5,6,6a,7,9,10-hexahydro-8H- pyrazino[1',2':4,5]pyrazino[2,3-c]pyridazin-8- yl)ethoxy)isoxazol-5-yl)-3-methylbutanoyl)- N-((S)-1-(4-(4-methyl-1lambda3,3lambda2-thiazol-5- yl)phenyl)ethyl)pyrrolidine-2-carboxamide (Mixture of Diastereomers at *)::US20240018158, Example 4
SMILES CC(C)[C@@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)c1cc(OCCN2CCN3C(CNc4nnc(cc34)-c3ccccc3O)C2)no1
InChI Key InChIKey=OTLUUZZFLYCKOU-ACVDEWQISA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 646015
TargetProbable global transcription activator SNF2L2(Homo sapiens (Human))
Prelude Therapeutics
US Patent
Prelude Therapeutics
US Patent
Affinity DataIC50: <100nMAssay Description:The inhibitory activity of compounds was evaluated in vitro using TR-FRET assay with white 384-well low volume microplate (PerkinElmer ProxiPlate Plu...More data for this Ligand-Target Pair